|
EU-Referenzserum ADV-gE A,
|
|
Community reference serum ADV-gE A,
|
|
|
EU-Referenzserum ADV-gE B,
|
|
Community reference serum ADV-gE B,
|
|
|
EU-Referenzserum ADV-gE C,
|
|
Community reference serum ADV-gE C,
|
|
|
EU-Referenzserum ADV-gE D,
|
|
Community reference serum ADV-gE D,
|
|
|
EU-Referenzserum ADV-gE E,
|
|
Community reference serum ADV-gE E,
|
|
|
EU-Referenzserum ADV-gE F.
|
|
Community reference serum ADV-gE F.
|
|
|
EU-Referenzserum ADV-gE G,
|
|
Community reference serum ADV-gE G,
|
|
|
EU-Referenzserum ADV-gE H,
|
|
Community reference serum ADV-gE H,
|
|
|
EU-Referenzserum ADV-gE J,
|
|
Community reference serum ADV-gE J,
|
|
|
EU-Referenzserum ADV-gE K,
|
|
Community reference serum ADV-gE K,
|
|
|
EU-Referenzserum ADV-gE L,
|
|
Community reference serum ADV-gE L,
|
|
|
EU-Referenzserum ADV-gE M,
|
|
Community reference serum ADV-gE M,
|
|
|
EU-Referenzserum ADV-gE N,
|
|
Community reference serum ADV-gE N,
|
|
|
EU-Referenzserum ADV-gE O,
|
|
Community reference serum ADV-gE O,
|
|
|
EU-Referenzserum ADV-gE P,
|
|
Community reference serum ADV-gE P,
|
|
|
GE-BIO-131
|
|
HR-BIO-131
|
|
|
GE-BIO-141
|
|
EG-BIO-141
|
|
|
Ge-samt-zeit
|
|
Total time
|
|
|
Ge-schlecht
|
|
Gender
|
|